Back
Protagonist Therapeutics Vs. Root Industry Stock Comparison
Buy
71
PTGX
Protagonist Therapeutics
Last Price:
31.68
Seasonality Move:
18.27%
Buy
54
ROOT
Root
Last Price:
62.24
Seasonality Move:
12.67%
Buy
71
Protagonist Therapeutics (PTGX)
is a Buy
Is Protagonist Therapeutics a Buy, Sell or Hold?
- The current Protagonist Therapeutics [PTGX] share price is $31.26. The Score for PTGX is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
- PTGX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
54
Root (ROOT)
is a Buy
Is Root a Buy, Sell or Hold?
- The current Root [ROOT] share price is $63.78. The Score for ROOT is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- ROOT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PTGX Stock Price Chart
What is Protagonist Therapeutics's stock price today?
-
The Protagonist Therapeutics share price today is $31.26
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTGX is experiencing buying pressure, which is a positive indicator for future bullish movement.
ROOT Stock Price Chart
PTGX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.11 | Buy |
| Relative Strength Index (14 RSI): | 67.71 | Buy |
| Chaikin Money Flow: | 187055 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (24.94 - 29.38) | Buy |
| Bollinger Bands (100): | (24.8 - 29.5) | Buy |
ROOT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.18 | Buy |
| Relative Strength Index (14 RSI): | 52.66 | Buy |
| Chaikin Money Flow: | -216089 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (56.03 - 66.49) | Buy |
| Bollinger Bands (100): | (12.63 - 62.87) | Buy |
PTGX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 30.11 | Buy |
| 20-day SMA: | 27.5 | Buy |
| 50-day SMA: | 27.78 | Buy |
| 200-day SMA: | 22.47 | Buy |
| 8-day EMA: | 30.07 | Buy |
| 20-day EMA: | 28.53 | Buy |
| 50-day EMA: | 27.69 | Buy |
| 200-day EMA: | 24.18 | Buy |
ROOT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 63.82 | Sell |
| 20-day SMA: | 62.94 | Buy |
| 50-day SMA: | 60.7 | Buy |
| 200-day SMA: | 23.89 | Buy |
| 8-day EMA: | 63.23 | Buy |
| 20-day EMA: | 62.58 | Buy |
| 50-day EMA: | 56.25 | Buy |
| 200-day EMA: | 31.69 | Buy |
Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $2.69 per share, an increase this year of $3.70 per share, and a decrease next year of $1.31 per share.
Root Earnings Growth & ROOT Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.30 per share, an increase next quarter of $1.05 per share, an increase this year of $6.29 per share, and an increase next year of $3.74 per share.
Protagonist Therapeutics Technical Analysis
| May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Root Technical Analysis
| May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||